Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
